Cordance Medical accepted into Endless Frontier Labs Deep Technology Accelerator

Cordance is one of 25 deep tech companies accepted out of 734 applicants to Endless Frontier Labs

Mountain View, Calif. – Cordance Medical has been accepted into the prestigious Endless Frontier Labs (EFL) deep technology track.  A total of 734 companies applied to be a part of the 2021 EFL program; of those, only 25 were accepted to the deep technology track.

“The acceptance of Cordance into one of the most competitive technology accelerator programs speaks volumes on the fundamentals of the Cordance technology and business,” said Ryan Dittamore, CEO at Cordance Medical. “We are thrilled to expand our network and gain access to leading technology mentors.”

The EFL program is a nine-month program running from October through May, focused on maximizing the potential of massively scalable, science and deep technology and is run through the NYU Stern School of Business.  Cordance will gain access to top technology mentors, financiers, and business services to position the company for growth and execution as part of the program.